Revvity price target raised to $28 from $23 at Barclays

Barclays raised the firm’s price target on Revvity (RVTY) to $28 from $23 and keeps an Overweight rating on the shares. The firm says the life science tools group will likely continue to work overall on the last estimate cut thesis and Q1 guides “coming in very conservative” that makes it hard to see companies missing targets.